Graham Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.4K | Buy |
24,824
+8,122
| +49% | +$29.2K | ﹤0.01% | 1176 |
|
|
2025
Q1 | $49.9K | Buy |
16,702
+4,191
| +33% | +$12.5K | ﹤0.01% | 1200 |
|
|
2024
Q4 | $41.9K | Buy |
+12,511
| New | +$41.9K | ﹤0.01% | 1156 |
|
|
2024
Q1 | – | Sell |
-11,387
| Closed | -$34.7K | – | 1034 |
|
|
2023
Q4 | $34.7K | Buy |
+11,387
| New | +$34.7K | ﹤0.01% | 924 |
|
|
2023
Q3 | – | Sell |
-10,113
| Closed | -$37.8K | – | 995 |
|
|
2023
Q2 | $37.8K | Buy |
+10,113
| New | +$37.8K | ﹤0.01% | 911 |
|
|
2022
Q4 | – | Sell |
-149,973
| Closed | -$853K | – | 1034 |
|
|
2022
Q3 | $853K | Buy |
149,973
+128,382
| +595% | +$730K | 0.03% | 541 |
|
|
2022
Q2 | $153K | Sell |
21,591
-54,226
| -72% | -$384K | 0.01% | 933 |
|
|
2022
Q1 | $547K | Buy |
75,817
+42,396
| +127% | +$306K | 0.02% | 512 |
|
|
2021
Q4 | $298K | Buy |
+33,421
| New | +$298K | 0.01% | 317 |
|